Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet
The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a red-hot market hinges on it.
Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don’t understand about obesity
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues and passengers I chatted with on airplanes: Is Ozempic right for me? Or any of the blockbuster weight loss and diabetes drugs that recently caught the world’s attention?
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.
How Often Do Doctors Use New Weight-Loss Drugs in Kids?
As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide and semaglutide are the only two GLP-1 drugs FDA-approved to treat obesity in kids ages 12 and up.
The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help unemployed people re-enter the workforce and ultimately save money on health care.
Dr. Sanjay Gupta explains the side effects of weight loss medications
From constipation to muscle loss, the side effects of some weight loss and diabetes medications can be daunting to patients. CNN’s Dr. Sanjay Gupta looks at why these effects occur, and gives some tips on how to keep them in check.
New Data: Nearly 50% of Weight-Loss Drug Patients Saw Lower Consumption of This, Too
"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports of the research.
Do Weight Loss Drugs Like Ozempic Affect Your Breast Health?
Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves dealing with an unexpected issue, what's become known as "Ozempic breasts." This possible side effect of glucagon-like peptide 1 (GLP-1) agonist medication users like Ozempic,
Hosted on MSN6d
Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.
Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...
New weight loss drug decreases appetite without nausea — and can even burn calories
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Medscape1d
Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
STAT3d
Amgen defends obesity drug amid bone concerns
After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
Benefits Pro3d
Obesity drug cost crisis will end, Swiss Re analysts say
Prachi Patkee and other analysts at Swiss Re offer that comfort to insurers, employers and patients in a new report on the impact of the new anti-obesity drugs on the insurance sectors.
Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...
STAT4d
BioNTech acquires its Chinese cancer drug partner
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...